Searching for Solutions

Why Diversity, Equity and Inclusion (DEI) Matters to AAPP As the home association for psychiatric pharmacy, AAPP advocates for appropriate use of medications, enhanced access to care, and improved patient outcomes.

Despite positive outcomes demonstrated by psychiatric pharmacists when integrated into healthcare teams, the financial investment required to integrate such services may be a barrier. The ability to demonstrate a return on investment (ROI) over a short period of time is imperative when persuading leadership to support a new clinical position.

The US is experiencing a severe shortage in mental health providers with an estimated 32% shortage of psychiatrists by 2030 and around $225 billion spent on mental health annually. To alleviate this shortage, the National Council for Behavioral Health Medical Director Institute endorses the use of advanced practice providers to improve patient access to mental health care, such as psychiatric nurse practitioners, physician assistants, and Board-Certified Psychiatric Pharmacists (BCPPs).

To establish new psychiatric pharmacist services, it should be recognized that substantial operational changes for the organization and staff are being proposed (see Change Management). Recognition of this can help improve one’s chances at successfully completing any proposed changes in how patients receive treatment. According to one model for managing complex change, there are five elements necessary for success.

As educators and advocates for evidence-based psychotropic medication management, BCPPs in CAP decrease polypharmacy, increase medication adherence and knowledge, and enhance patient outcomes. Given the need for interdisciplinary collaboration among BCPPs, child and adolescent psychiatrists, and primary care providers, it is crucial for pharmacy administrators to respond and recognize the necessity of integrating pharmacy services into CAP and integrating BCPPs into pharmacy departments.

Tanya J. Fabian, PharmD, PhD, BCPP Director, Pharmacy Research and Pharmacy Services Director, PGY2 Psychiatric Pharmacy Residency UPMC Western Psychiatric Hospital Associate Professor of Pharmacy & Therapeutics and Psychiatry University of Pittsburgh Schools of Pharmacy and Medicine

If you experience problems receiving email from CPNP, then your IT department (or ISP) probably errantly identified the email as spam. We ask that you add us to your trusted list of senders, contacts or address book. These techniques are also known as whitelisting. The initial step is generally to open your spam folder look for the missing email there, open it and mark it as "not spam"...

Genoa’s psychiatric pharmacy courses are offered in conjunction with the American Association of Psychiatric Pharmacists (AAPP), a membership association serving and driven by psychiatric pharmacists. These modules will close 12/31/2025. You can anticipate that each module will take you between 1 to 3 hours to complete depending on your learning style and preferences. Each module has a required examination. A score of 70% is required to successfully complete each exam.

Genoa is excited to support your continuing professional development (CPD) in the behavioral health arena. We are once again partnering with the American Association of Psychiatric Pharmacists (AAPP) to provide you with psychiatric specialty training through select modules from AAPP’s Psychiatric Pharmacotherapy Review Course!